Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalcetrapib Extension Study in CHD
NCT00400439Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalcetrapib in coronary heart disease (CHD), sponsored by Roche. Started Jan 2007; status: completed.
02
Drugs
dalcetrapib
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00400439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400439.